https://www.has-sante.fr/jcms/p_3689712/fr/reevaluation-des-specialites-indiquees-dans-le-traitement-hormonal-de-la-menopause-estradiol-estriol-tibolone-acetate-de-cyproterone-dydrogesterone-levonorgestrel-medrogestone-medroxyprogesterone-acetate-de-norethisterone-progesterone 2025 France evaluation of the transparency committee progesterone menopause tibolone Norethindrone Acetate medrogestone progesterone estradiol cyproterone acetate menopause, nos estriol hormones hormone, nos tibolone dydrogesterone estradiol estrogen replacement therapy indicators and reagents medroxyprogesterone acetate levonorgestrel hormonotherapy acetate suggestive of estriol indication of estradiol, estriol drug combination cyproterone cyproterone acetate
--- https://assurance-maladie.ameli.fr/etudes-et-donnees/2022-impact-actions-acetate-cyproterone-meningiome 2022 France technical report cyproterone acetate intracranial meningioma meningioma meningioma, nos cyproterone risk reduction behavior measures risk assessment weights and measures Meningioma cranial cavity, nos acetate cyproterone acetate risk reduction
--- https://assurance-maladie.ameli.fr/etudes-et-donnees/2019-acetate-cyproterone-meningiome 2019 France technical report female cyproterone women effects of exposure to external cause, nos Exhibition risk meningioma, nos long meningioma acetate cyproterone acetate cyproterone acetate Meningioma